CARLSBAD, Calif., Nov. 24, 2015 /PRNewswire/ -- Alastin Skincare, Inc. (www.alastin.com)—a specialty skincare company dedicated to developing and marketing innovative, clinically-tested skincare products that enhance, protect, and maintain healthy skin for a lifetime—has announced the appointment of Diane S. Goostree as its new President & CEO effective January 4th, 2016. She will succeed founder Scott L. Glenn who will remain as Chairman.
Ms. Goostree joins Alastin Skincare with 30 years of experience in both private and public pharmaceutical, medical device and cosmeceutical companies. Ms. Goostree is a successful business leader who has led the development and marketing of both prescription and physician dispensed skincare products. She was a key executive driving the early development and growth of SkinMedica and recently served as CEO of Intrepid Therapeutics, a development-stage prescription dermatology company. Ms. Goostree holds a Bachelor of Science degree in Chemical Engineering and an MBA.
Scott L. Glenn, Alastin's Chairman, who personally conducted the search for Alastin's CEO, expressed his excitement at Ms. Goostree's appointment saying, "Diane is a very experienced executive with a strong clinical, scientific and commercial background. She is an excellent choice to lead Alastin as the company continues to roll out its procedure enhancement products and expands its product line and national presence."
About Alastin Skincare, Inc.:
Alastin Skincare™ is dedicated to developing innovative, clinically-tested skin care products that correct, protect, and maintain healthy skin for a lifetime. Our unparalleled procedure enhancement products are formulated with a combination of proprietary peptides using the latest technology and are clinically tested to ensure both safety and effectiveness to reawaken the skin's youthful processes.
SOURCE Alastin Skincare, Inc.